<DOC>
	<DOCNO>NCT01902810</DOCNO>
	<brief_summary>This efficacy safety trial examine effect safety propranolol administer adult patient severe burn injury . The investigator hypothesize propranolol provide significant benefit adult follow severe burn injury dos safe increase risk adverse infectious non-infectious outcome .</brief_summary>
	<brief_title>Protective Effects Propranolol Adults</brief_title>
	<detailed_description>A safety efficacy trial need order determine safety propranolol treatment adult burn patient , identify subpopulation may likely benefit propranolol treatment identify propranolol dose level safe potentially effective .</detailed_description>
	<mesh_term>Propranolol</mesh_term>
	<criteria>≥ 20 % Total Body Surface Area ( TBSA ) burn anticipate operation need admission Age ≥ 18 year Admission within 72 hour injury Age &lt; 18 Patients unlikely survive injury ; age = total burn size ≥ 130 Electrical deep chemical burn Malignancy currently undergo treatment history cancer treatment within 5 year History HIV AIDS Presence anoxic brain injury expect result complete recovery Currently treat Chronic Obstructive Pulmonary Disease ( COPD ) , asthma chronic pulmonary condition History Congestive Heart Failure ( CHF ) ( ejection fraction &lt; 20 % ) Preinjury medication include block agent ( alpha beta ) antiarrhythmic drug Pregnant woman Prisoners History cardiac arrhythmia require medication Medical condition require glucocorticoid treatment Patients concurrent condition opinion investigator may compromise patient safety study objective</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>